Send to a Friend Font Size: Increase Decrease

REPL and IOVA Related Headlines

Apr 10, 2026 01:20PM Jefferies on Iovanace Biotherapeutics (IOVA): 'we think the pot'l risk of competition was accounted for in Street models'

REPL and IOVA Related Press Releases

REPL and IOVA Related SEC Filings